US OptionsDetailed Quotes
BMY240726C48000
- 0.27
- +0.18+200.00%
15min DelayClose Jul 25 16:00 ET
0.38High0.10Low
0.10Open0.09Pre Close1.28K Volume1.10K Open Interest48.00Strike Price32.25KTurnover144.29%IV6.63%PremiumJul 26, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.27Extrinsic Value100Contract SizeAmericanOptions Type0.1850Delta0.0936Gamma161.68Leverage Ratio-0.5497Theta0.0002Rho29.91Eff Leverage0.0053Vega
Bristol-Myers Squibb Stock Discussion
Gapping up
$Coinbase(COIN.US)$ 's stock saw a 5.2% increase as it followed the rise in bitcoin prices, with the leading cryptocurrency up approximately 4% after a downturn the previous day.
Semiconductor stocks experienced a rebound, with $NVIDIA(NVDA.US)$ , $Broadcom(AVGO.US)$ , $Qualcomm(QCOM.US)$ , and $Micron Technology(MU.US)$ all posting gains exceeding 2%. This movement came as the sector attempted to r...
📊⚡️📊
Bristol Myers Squibb $Bristol-Myers Squibb(BMY.US)$ , Cisco S...
good news with share drops doent understand this share.
so many good news. but the share just never go up and yet keep on dropping .
📌 This week’s PDUFAs:
$Merck & Co(MRK.US)$ : 🤔
⇨ Patritumab deruxtecan
‣ Non-small cell lung carcinoma
‣ PDUFA date: 6/26/24 (BLA)
$Verona Pharma(VRNA.US)$ : 🤔
⇨ Ensifentrine (Nebulized)
‣ Chronic obstructive pulmonary disease
‣ PDUFA date: 6/26/24 (NDA)
$Genmab(GMAB.US)$ : 🤔
⇨ EPKINLY® (Epcoritamab)
‣ Follicular lymphoma
‣ PDUFA date: 6/28/24 (sBLA)
🗓️ Last week’s PDUFAs:
$Merck & Co(MRK.US)$ : Approved 6/17 🎉
⇨ CAPVAXIVE (V116)
‣ Pneumo...
$CAVA Group(CAVA.US)$ : “Cava feels like it has the possibility of being a Chipotle. So, even though I know it just had a big spike, I would not abandon it. I would just look to buy more if it came down.”
$Rubrik(RBRK.US)$ : “It’s a good company, but the problem is, again, this market hates enterprise software.”
$Forward Air(FWRD.US)$ : “There’s g...
$Harmony Biosciences(HRMY.US)$ : WAKIX (pitolisant)
$Bristol-Myers Squibb(BMY.US)$ : KRAZATI (Adagrasib) + Cetuximab
$argenx SE(ARGX.US)$ : VYVGART Hytrulo (Efgartigimod)
$Merck & Co(MRK.US)$ : Patritumab deruxtecan
$Verona Pharma(VRNA.US)$ : Ensifentrine (Nebulized)
$Rocket Pharmaceuticals(RCKT.US)$ : KRESLADI (Marnetegragene autotemcel)
$Bristol-Myers Squibb(BMY.US)$ is a global biopharmaceutical company known for its innovative treatments in oncology, immunology, and cardiovascular diseases. Over the past year, BMY has faced some challenges, with its stock price nearing its 52-week low. As of June 20, 2024, the stock is trading at $40.795, which is close to its 52-week low of around $40.00.
$Bristol-Myers Squibb(BMY.US)$
Despite recent performance s...
No comment yet